Stephan C Bischoff1. 1. University of Hohenheim, 70593 Stuttgart, Germany. bischoff.stephan@uni-hohenheim.de
Abstract
PURPOSE OF REVIEW: Eosinophilic gastroenteritis (EGE) and eosinophilic colitis (ECO) are two forms of chronic inflammatory disorders of the gastrointestinal tract characterized by eosinophil accumulation in the mucosa or in deeper layers of the gastrointestinal wall and associated with atopic disease. The eosinophilic gastrointestinal diseases broadened the spectrum of atopic gastrointestinal disorders formerly restricted to food allergy manifestating at the gastrointestinal mucosa. Their awareness increased enormously; therefore, we will review current knowledge about atopic gastrointestinal diseases for the allergologist. RECENT FINDINGS: Major attention will be drawn to the differential diagnosis, because symptoms of atopic gastrointestinal diseases frequently mimic those of other chronic inflammatory bowel diseases (IBDs) or irritable bowel syndrome (IBS), although the diseases are distinct in their histopathology, gene expression signature, response to therapy, and association with allergies. The pathogenesis of EGE and ECO will be described that involves environmental and genetic factors, particularly food antigens and expression level of interleukin (IL)-5 and selective chemokines. SUMMARY: Understanding symptoms and pathology of such disease is the basis of a rational treatment based on reduced exposure to offending food antigens as well as anti-inflammatory therapy. Atopic gastrointestinal diseases are in many cases reversible; however, chronic treatment is often necessary to prevent relapse.
PURPOSE OF REVIEW: Eosinophilic gastroenteritis (EGE) and eosinophilic colitis (ECO) are two forms of chronic inflammatory disorders of the gastrointestinal tract characterized by eosinophil accumulation in the mucosa or in deeper layers of the gastrointestinal wall and associated with atopic disease. The eosinophilic gastrointestinal diseases broadened the spectrum of atopic gastrointestinal disorders formerly restricted to food allergy manifestating at the gastrointestinal mucosa. Their awareness increased enormously; therefore, we will review current knowledge about atopic gastrointestinal diseases for the allergologist. RECENT FINDINGS: Major attention will be drawn to the differential diagnosis, because symptoms of atopic gastrointestinal diseases frequently mimic those of other chronic inflammatory bowel diseases (IBDs) or irritable bowel syndrome (IBS), although the diseases are distinct in their histopathology, gene expression signature, response to therapy, and association with allergies. The pathogenesis of EGE and ECO will be described that involves environmental and genetic factors, particularly food antigens and expression level of interleukin (IL)-5 and selective chemokines. SUMMARY: Understanding symptoms and pathology of such disease is the basis of a rational treatment based on reduced exposure to offending food antigens as well as anti-inflammatory therapy. Atopic gastrointestinal diseases are in many cases reversible; however, chronic treatment is often necessary to prevent relapse.
Authors: Jacob Mark; Shahan D Fernando; Joanne C Masterson; Zhaoxing Pan; Kelley E Capocelli; Glenn T Furuta; Edwin F de Zoeten Journal: J Pediatr Gastroenterol Nutr Date: 2018-05 Impact factor: 2.839
Authors: Shuk-Mei Ho; James D Lewis; Emeran A Mayer; Scott E Plevy; Emil Chuang; Stephen M Rappaport; Kenneth Croitoru; Joshua R Korzenik; Jeffrey Krischer; Jeffrey S Hyams; Richard Judson; Manolis Kellis; Michael Jerrett; Gary W Miller; Melanie L Grant; Nataly Shtraizent; Gerard Honig; Andrés Hurtado-Lorenzo; Gary D Wu Journal: Inflamm Bowel Dis Date: 2019-05-16 Impact factor: 5.325
Authors: Elizabeth T Jensen; Christopher F Martin; Michael D Kappelman; Evan S Dellon Journal: J Pediatr Gastroenterol Nutr Date: 2016-01 Impact factor: 2.839
Authors: David S Kotlyar; Mili Shum; Jennifer Hsieh; Wojciech Blonski; David A Greenwald Journal: World J Gastroenterol Date: 2014-08-28 Impact factor: 5.742
Authors: Kriszta Molnár; Petra Pintér; Hajnalka Győrffy; Aron Cseh; Katalin Eszter Müller; András Arató; Gábor Veres Journal: World J Gastroenterol Date: 2013-06-28 Impact factor: 5.742